Home / Inspections / 1041022

FDA Inspection 1041022 — Aspire Houston Fertility Institute

Aspire Houston Fertility Institute — FEI 1000543561

The FDA completed an inspection of Aspire Houston Fertility Institute on January 24, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1249226 (NAI Wed Aug 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117002 (VAI Thu Feb 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014004 (NAI Mon Dec 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 695932 (VAI Mon Nov 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources